Kenneth Hon Kim Ban

Kenneth obtained his BSc (Hons) in Biochemistry and MBBS degrees from the National University of Singapore (NUS) and a PhD in Cancer Biology from Stanford University. He completed his postdoctoral training in mouse cancer genetics at the Institute of Molecular and Cell Biology (IMCB) Singapore before joining the Department of Biochemistry at NUS. He also serves as the Program Director for Health/Biomedical and Life Sciences at the National Supercomputing Centre (NSCC) Singapore. His research and education interests are in cancer genetics, high-performance computing for precision medicine, and the development of technology-enhanced learning platforms for medical and health/bioinformatics education.

RESEARCH INTEREST(S)

• Prostate Cancer
• Breast Cancer
• Transposon Screens
• High-Performance Computing
• Mouse Models
• Translational Bioinformatics
• Technology-enhanced Medical Education

Education

• PhD Stanford University (2001 — 2007)
• MBBS National University of Singapore (1990 — 1996)
• BSc(Hons) National University of Singapore (1991 — 1992)

Companies

• Assistant Principal Investigator Institute of Molecular and Cell Biology (2011)
• Assistant Professor National University of Singapore (2011)
• Senior Tutor National University of Singapore (2000 — 2001)
• Medical Officer/Resident Ministry of Health Singapore (1997 — 2000)

RECENT PUBLICATIONS

• Lin, M., Lee, P. L., Chiu, L., Chua, C., Ban, K. H. K., Lin, A. H. F., . . . Chng, W. J. (2018). Identification of novel fusion transcripts in multiple myeloma. Journal of Clinical Pathology.
• Kundu, S., Ali, M. A., Handin, N., Padhan, N., Larsson, J., Karoutsou, M., . . . Sjöblom, T. (2018). Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genomewide forward genetic screen in human colorectal cancer cells. Genome Medicine, 10(1).
• Ng, C. W. S., Kosmo, B., Lee, P. -L., Lee, C. K., Guo, J., Chen, Z., . . . Yan, B. (2018). CEBPA mutational analysis in acute myeloid leukaemia by a laboratory-developed next-generation sequencing assay. JOURNAL OF CLINICAL PATHOLOGY, 71(6), 522-531.
• Ng, I. K. S., Ng, C., Low, J. J., Chiu, L., Seah, E., Ng, C. H., . . . Ban, K. H. K. (2017). Identifying large indels in targeted next generation sequencing assays for myeloid neoplasms: a cautionary tale of the ZRSR1 pseudogene. JOURNAL OF CLINICAL PATHOLOGY, 70(12), 1069-1073.
• Chen, L., Jenjaroenpun, P., Pillai, A. M. C., Ivshina, A. V., Ow, Z. S., Efthimios, M., . . . Thiery, J. P. (2017). Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification. Proceedings of the National Academy of Sciences of the United States of America, 114(11), E2215-E2224.